Generex Biotechnology Corp Stock Technical Analysis

GNBTDelisted Stock  USD 0.0001  0.00  0.00%   
As of the 2nd of May, Generex Biotechnology retains the Risk Adjusted Performance of 0.0687, market risk adjusted performance of 0.5496, and Downside Deviation of 61.9. Generex Biotechnology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed nineteen technical drivers for Generex Biotechnology, which can be compared to its competitors. Please check out Generex Biotechnology coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Generex Biotechnology is priced fairly, providing market reflects its last-minute price of 1.0E-4 per share. As Generex Biotechnology appears to be a penny stock we also urge to confirm its total risk alpha numbers.

Generex Biotechnology Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Generex, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Generex
  
Generex Biotechnology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Generex Biotechnology technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Generex Biotechnology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Generex Biotechnology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Generex Biotechnology Technical Analysis

Indicator
Time Period
Execute Indicator
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Generex Biotechnology Trend Analysis

Use this graph to draw trend lines for Generex Biotechnology Corp. You can use it to identify possible trend reversals for Generex Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Generex Biotechnology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Generex Biotechnology Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Generex Biotechnology Corp applied against its price change over selected period. The best fit line has a slop of    , which may suggest that Generex Biotechnology Corp market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Generex Biotechnology price change compared to its average price change.

About Generex Biotechnology Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Generex Biotechnology Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Generex Biotechnology Corp based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Generex Biotechnology price pattern first instead of the macroeconomic environment surrounding Generex Biotechnology. By analyzing Generex Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Generex Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Generex Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.

Generex Biotechnology May 2, 2024 Technical Indicators

Most technical analysis of Generex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Generex from various momentum indicators to cycle indicators. When you analyze Generex charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Generex Biotechnology information on this page should be used as a complementary analysis to other Generex Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Generex OTC Stock

If you are still planning to invest in Generex Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Generex Biotechnology's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities